Ovarian cancer: Patterns of surgical care across the United States

Gynecologic Oncology

Volumn 103, Issue 2, 2006, Pages 383-390

  Goff, Barbara A ^a   Matthews, Barbara J ^a   Wynn, Michelle ^b   Muntz, Howard G ^c   Lishner, Denise M ^a   Baldwin, Laura Mae ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c VIRGINIA MASON MEDICAL CENTER   (United States)

Author keywords

Ovarian cancer; Surgical care

Indexed keywords

ADULT; APPENDECTOMY; ARTICLE; BLOOD TRANSFUSION; COLOSTOMY; CYTOREDUCTIVE SURGERY; FEMALE; HEART DISEASE; HOSPITAL DISCHARGE; HOSPITALIZATION; HOUSEHOLD; HUMAN; HYSTERECTOMY; INCOME; INFECTION; INTESTINE SURGERY; LAPAROSCOPIC SURGERY; LUNG DISEASE; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; OVARIECTOMY; OVARY CANCER; PRIORITY JOURNAL; REOPERATION; SPLENECTOMY; SURGEON; SURGICAL INJURY; TEACHING HOSPITAL; UNITED STATES;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; GYNECOLOGIC SURGICAL PROCEDURES; HUMANS; MIDDLE AGED; OVARIAN NEOPLASMS; OVARIECTOMY; PHYSICIAN'S PRACTICE PATTERNS; SOCIOECONOMIC FACTORS; UNITED STATES;

EID: 33750154169     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2006.08.010     Document Type: Article

References (29)

1. Hoskins W, Rice L, Rubin S. Ovarian cancer surgical practice guidelines. society of surgical oncology practice guidelines: ovarian cancer. Oncology-Huntington 1997;11(6):896-900, 903-4.
2. Bristow R.E., Tomacruz R.S., Armstrong D.K., Trimble E.L., and Montz F.J. Survival effect of maximal cytroreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis. J. Clin. Oncol. 20 5 (2002) 11248-11259
3. Eisenkop S.M., Spirtos N.M., Montag T.W., Nalick R.H., and Wang H.J. The impact of subspecialty training on the management of advanced ovarian cancer. Gynecol. Oncol. 47 (1992) 203-209
4. Hoffman M.S., Griffin D., Tebes S., Cardosi R.J., Martino M.A., Fiorica J.V., et al. Sites of bowel resected to achieve optimal ovarian cancer cytoreduction: implications regarding surgical management. Am. J. Obstet. Gynecol. 193 (2005) 582-588
5. Chi D.S., Franklin C.C., Levine D.A., Akselrod F., Sabbatini P., Jarnagin W.R., et al. Improved optimal cytoreduction rates for stages IIIC and IV epithelial ovarian, fallopian tube, and primary peritoneal cancer: a change in surgical approach. Gynecol. Oncol. 94 (2004) 650-654
6. Bristow R.E., Montz F.J., Lagasse L.D., Leuchter R.S., and Karlan B.Y. Survival Impact of surgical cytoreduction in stage IV epithelial ovarian cancer. Gynecol. Oncol. 72 (1999) 278-287
7. Harlan L.C., Clegg L.X., and Trimble E.L. Trends in surgery and chemotherapy for women diagnosed with ovarian cancer in the United States. J. Clin. Oncol. 21 18 (2003) 3488-3494
8. Agency for Healthcare Research and Quality. HCUP databases. Available at: http://www.hcup-us.ahrq.gov/databases.jsp. Accessed May 19, 2006.
9. Morrill R., Cromartie J., and Hart L.G. Metropolitan, urban, and rural commuting areas: toward a better depiction of US Settlement System. Urban Geogr. 20 (1999) 727-748
10. Wolfe C.D.A., Tilling K., and Raju K.S. Management and survival of ovarian cancer patients in south east England. Eur. J. Cancer 33 11 (1997) 1835-1840
11. Tingulstad S., Skjeldestad F.E., and Hagen B. The effect of centralization of primary surgery on survival in ovarian cancer patients. Obstet. Gynecol. 102 3 (2003) 499-505
12. National Institutes of Health Consensus Development Conference Statement. Ovarian cancer: screening, treatment, and followup. Gynecol. Oncol. 55 (1994) S4-S14
13. Goff BA, Larson E, Matthews B, Andrilla H, Lackey M, Lishner, D, et al. What factors predict comprehensive surgical treatment of ovarian cancer patients? Gynnecol Oncol 2006; 101:S1.
14. Junor E.J., Hole D.J., McNulty L., Mason M., and Young J. Specialist gynaecologists and survival outcome in ovarian cancer: a Scottish national study of 1866 patients. Br. J. Obstet. Gynaecol. 106 (1999) 1130-1136
15. Olaitan A., Weeks J., Mocroft A., Smith J., Howe K., and Murdoch J. The surgical management of women with ovarian cancer in the south west of England. Br. J. Cancer 85 12 (2001) 1824-1830
16. Munstedt K., von Georgi R., Misselwitz B., Zygmunt M., Stillger R., and Kunzel W. Centralizing surgery for gynecologic oncology - a strategy assuring better quality treatment?. Gynecol. Oncol. 89 (2003) 4-8
17. Kehoe S., Powell J., Wilson S., and Woodman C. The influence of the operating surgeon's specialisation on patient survival in ovarian carcinoma. Br. J. Obstet. Gynaecol. 105 4 (1998) 468-470
18. Carney M.E., Lancaster J.M., Ford C., Tsodikov A., and Wiggins C.L. A population-based study of patterns of care for ovarian cancer: who is seen by a gynecologic oncologist and who is not?. Gynecol. Oncol. 84 (2002) 36-42
19. Bristow R.E., Zahurak M.L., del Carmen M.G., Gordon T.A., Fox H.E., Trimble E.L., and Montz F.J. Ovarian cancer surgery in Maryland: volume-based access to care. Gynecol. Oncol. 93 (2004) 353-360
20. Schrag D., Earle C., Xu F., Panageas K.S., Yabroff K.R., Bristow R.E., et al. Associations between hospital and surgeon procedure volumes and patient outcomes after ovarian cancer resection. JNCI 98 3 (2006) 163-171
21. Earle C.C., Schrag D., Neville B.A., Yabroff K.R., Topor M., Fahey A., et al. Effect of surgeon specialty on processes of care and outcomes for ovarian cancer patients. J. NCI 98 3 (2006) 172-180
22. Elit L., Bondy S.J., Paszat L., Przybysz R., and Levine R. Outcomes in surgery for ovarian cancer. Gynecol. Oncol. 87 (2002) 260-267
23. Munoz K.A., Harlan L.C., and Trimble E.L. Patterns of care for women with ovarian cancer in the United States. J. Clin. Oncol. 15 11 (1997) 3408-3415
24. Lathan C.S., Neville B.A., and Earle C.C. The effect of race on invasive staging and surgery in non-small-cell lung cancer. J. Clin. Oncol. (2005 (Dec 19)) [JCO Early Release]
25. Tawari A., Hominger W., Pelzer A.E., Demers R., Crawford E.D., Gamito E.J., et al. Factors contributing to the racial differences in prostate cancer mortality. BJU Int. 96 9 (2005) 1247-1252
26. Voti L., Richardson L., Reis I., Fleming L.E., MacKinnon J., and Coebergh J.W.W. The effect of race/ethnicity and insurance in the administration of standard therapy for local breast cancer in Florida. Breast Cancer Res. Treat. (2005 (Oct 22)) 1-7
27. van der Burg M.E.L., van Lent M., Buyse M., Kobierska A., Colombo N., Favalli G., et al. The effect of debulking surgery after induction chemotherapy on the prognosis in advanced epithelial ovarian cancer. N. Engl. J. Med. 332 (1995) 629-634
28. Rose P.G., Nerenstone S., Brady M.F., Clarke-Pearson D., Olt G., Rubin S.T., et al. Secondary surgical cytoreduction for advanced ovarian carcinoma. N. Engl. J. Med. 351 24 (2004) 2489-2497
29. Aletti G.D., Dowdy S.C., Gostout B.S., Jones M.B., Stanhope C.R., Wilson T.O., et al. Aggressive surgical effort and improved survival in advanced-stage ovarian cancer. Obstet. Gynecol. 107 1 (2006) 77-85